AxoGen's GAAP loss for 9 months of 2020 was $17.776 million, down 19.6% from $22.097 million the previous year. Revenue increased 1.6% to $79.805 million, against $78.55 million a year earlier.
AxoGen's GAAP loss for 9 months of 2020 was $17.776 million, down 19.6% from $22.097 million the previous year. Revenue increased 1.6% to $79.805 million, against $78.55 million a year earlier. 
ir.axogeninc.com
English (US) 